despite neutral imaging results, adalimumab did improve other key markers of inflammation in the blood including glyca, crp, tnf, and il-6. . .
-
.
stephen silberstein, md, director, jefferson university headache center.
OFF DEAL
218 Used Today
OFF DEAL
200 Used Today